AI Brief

AI News Brief: OpenAI has officially launched the ‘Rosalind Biodefense’ initiative, expanding access to GPT-Rosalind, its dedicated biology-focused model, to specific groups. The rollout uses a ’trusted access’ mechanism, limiting eligibility to two categories: developers who pass a qualification review, and US government partners advancing biodefense work. The initiative focuses on three core application areas: biodefense…

AI news brief: Boston Children’s Hospital has rolled out OpenAI technology across three areas — improving patient care quality, reducing internal administrative workload, and assisting with rare disease diagnosis. The most concrete result so far is helping doctors confirm diagnoses in over 40 rare disease cases, a category where complex symptoms and scarce literature typically stretch out the diagnostic process for years.